| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
38,007 |
30,935 |
$2.14M |
| 99199 |
Unlisted special service, procedure or report |
292,848 |
158,729 |
$1.82M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
12,563 |
10,238 |
$1.06M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
11,717 |
9,094 |
$898K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
8,982 |
7,645 |
$738K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
17,349 |
14,000 |
$736K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,901 |
2,545 |
$249K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,898 |
2,296 |
$94K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,041 |
2,546 |
$64K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,364 |
2,866 |
$41K |
| 97802 |
|
3,572 |
2,856 |
$38K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
289 |
255 |
$28K |
| 92551 |
|
9,543 |
7,997 |
$23K |
| 99383 |
|
372 |
207 |
$20K |
| 99173 |
|
10,794 |
9,043 |
$13K |
| 99381 |
|
235 |
148 |
$13K |
| 99382 |
|
245 |
157 |
$13K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
650 |
501 |
$10K |
| D0145 |
Oral evaluation for a patient under three years of age |
258 |
219 |
$8K |
| 87807 |
|
633 |
506 |
$8K |
| 90461 |
|
3,636 |
2,928 |
$7K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
217 |
187 |
$7K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
84 |
69 |
$6K |
| 99215 |
Prolong outpt/office vis |
50 |
37 |
$6K |
| 83655 |
|
397 |
317 |
$5K |
| 99051 |
|
208 |
181 |
$5K |
| D1206 |
Topical application of fluoride varnish |
256 |
218 |
$4K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
94 |
81 |
$3K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
27 |
24 |
$3K |
| 96161 |
|
797 |
670 |
$3K |
| 85018 |
|
1,566 |
1,263 |
$2K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
125 |
113 |
$2K |
| 90686 |
|
1,609 |
1,182 |
$1K |
| A4627 |
Spacer, bag or reservoir, with or without mask, for use with metered dose inhaler |
32 |
25 |
$838.72 |
| 94664 |
|
79 |
63 |
$735.63 |
| 96127 |
|
182 |
168 |
$689.54 |
| 90674 |
|
453 |
362 |
$283.73 |
| 90651 |
|
18 |
13 |
$260.44 |
| 96380 |
|
13 |
12 |
$205.68 |
| 90633 |
|
565 |
476 |
$107.62 |
| 90744 |
|
737 |
601 |
$84.00 |
| 1160F |
|
47,235 |
37,425 |
$53.22 |
| 90715 |
|
24 |
17 |
$44.68 |
| 81003 |
|
30 |
28 |
$34.08 |
| 3078F |
|
9,783 |
8,243 |
$0.23 |
| 2001F |
|
31,473 |
25,198 |
$0.00 |
| 3008F |
|
11,117 |
9,509 |
$0.00 |
| 90680 |
|
1,273 |
977 |
$0.00 |
| 90698 |
|
2,200 |
1,751 |
$0.00 |
| 99000 |
|
4,368 |
3,351 |
$0.00 |
| 3074F |
|
10,139 |
8,528 |
$0.00 |
| 90677 |
|
476 |
439 |
$0.00 |
| 90716 |
|
538 |
444 |
$0.00 |
| 90696 |
|
16 |
12 |
$0.00 |
| 90707 |
|
528 |
396 |
$0.00 |
| 90670 |
|
3,592 |
2,815 |
$0.00 |
| 90685 |
|
128 |
107 |
$0.00 |
| 90661 |
|
324 |
315 |
$0.00 |
| 90700 |
|
55 |
48 |
$0.00 |
| 90734 |
|
24 |
17 |
$0.00 |